These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24773097)

  • 1. Incremental costs associated with myocardial infarction and stroke in patients with type 2 diabetes mellitus: an overview for economic modeling.
    Brennan VK; Colosia AD; Copley-Merriman C; Mauskopf J; Hass B; Palencia R
    J Med Econ; 2014 Jul; 17(7):469-80. PubMed ID: 24773097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility estimates for patients with Type 2 diabetes mellitus after experiencing a myocardial infarction or stroke: a systematic review.
    Brennan VK; Mauskopf J; Colosia AD; Copley-Merriman C; Hass B; Palencia R
    Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):111-23. PubMed ID: 25555462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular event costs in patients with Type 2 diabetes mellitus.
    Johnston SS; Sheehan JJ; Shah M; Cappell K; Princic N; Smith D; Kalsekar I
    J Med Econ; 2015; 18(12):1032-40. PubMed ID: 26189723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population.
    Kern DM; Mellström C; Hunt PR; Tunceli O; Wu B; Westergaard M; Hammar N
    Curr Med Res Opin; 2016; 32(4):703-11. PubMed ID: 26709864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden.
    Ringborg A; Yin DD; Martinell M; Stålhammar J; Lindgren P
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):576-82. PubMed ID: 19491686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
    King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
    Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany.
    Kähm K; Laxy M; Schneider U; Rogowski WH; Lhachimi SK; Holle R
    Diabetes Care; 2018 May; 41(5):971-978. PubMed ID: 29348194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular event incidence and cost in type 2 diabetes mellitus: a Medicare claims-based actuarial analysis.
    Fitch K; Engel T; Sander S; Kuti E; Blumen H
    Curr Med Res Opin; 2017 Oct; 33(10):1795-1801. PubMed ID: 28641023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review.
    Einarson TR; Acs A; Ludwig C; Panton UH
    Value Health; 2018 Jul; 21(7):881-890. PubMed ID: 30005761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The direct medical cost of type 2 diabetes.
    Brandle M; Zhou H; Smith BR; Marriott D; Burke R; Tabaei BP; Brown MB; Herman WH
    Diabetes Care; 2003 Aug; 26(8):2300-4. PubMed ID: 12882852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain.
    Ray JA; Valentine WJ; Secnik K; Oglesby AK; Cordony A; Gordois A; Davey P; Palmer AJ
    Curr Med Res Opin; 2005 Oct; 21(10):1617-29. PubMed ID: 16238902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).
    Clarke P; Gray A; Legood R; Briggs A; Holman R
    Diabet Med; 2003 Jun; 20(6):442-50. PubMed ID: 12786677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of the costs and benefits of helicopter emergency medical services.
    Taylor CB; Stevenson M; Jan S; Middleton PM; Fitzharris M; Myburgh JA
    Injury; 2010 Jan; 41(1):10-20. PubMed ID: 19853251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort.
    Laxy M; Schöning VM; Kurz C; Holle R; Peters A; Meisinger C; Rathmann W; Mühlenbruch K; Kähm K
    Pharmacoeconomics; 2019 Dec; 37(12):1485-1494. PubMed ID: 31350720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000.
    O'Brien JA; Patrick AR; Caro J
    Clin Ther; 2003 Mar; 25(3):1017-38. PubMed ID: 12852716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic impact of implementing a multiple inflammatory biomarker-based approach to identify, treat, and reduce cardiovascular risk.
    Penn MS; Yenikomshian MA; Cummings AK; Klemes A; Damron JM; Purvis S; Beidelschies M; Birnbaum HG
    J Med Econ; 2015; 18(7):483-91. PubMed ID: 25763924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual direct medical costs associated with diabetes-related complications in the event year and in subsequent years in Hong Kong.
    Jiao F; Wong CKH; Tang SCW; Fung CSC; Tan KCB; McGhee S; Gangwani R; Lam CLK
    Diabet Med; 2017 Sep; 34(9):1276-1283. PubMed ID: 28636749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.